Thursday, July 23, 2020

New cancer clinical trial: RPCRC Validation Study

Published on: July 23, 2020 at 07:00PM
Condition:   Multivariate Risk Assessment for ISUP ≥2 Prostate Cancer
Intervention:   Other: Assessment of the diagnostic performance of the PI-RADS score (as a stand-alone) and of the RPCRC for predicting the presence of ISUP ≥2 prostate cancer at subsequent biopsy in 251 patients.
Sponsor:   Hospices Civils de Lyon
Active, not recruiting

No comments:

Post a Comment